4833M 15/850 (Actoplus Met 850 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill with imprint 4833M 15/850 is White, Elliptical/Oval and has been identified as Actoplus Met 850 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc.
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4833M 15/850
- Generic Name
- 4833M 15/850
- 850 mg / 15 mg
- 18.00 mm
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- Inactive Ingredients
hypromellose 2910 (6 mPa.s),
polyethylene glycol 8000,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|64764-0158||Takeda Pharmaceutical Company Limited|
|00093-5050 (Discontinued)||Teva Pharmaceuticals USA, Inc.|
|42291-0694 (Discontinued)||AvKare, Inc.|
|54868-5553 (Discontinued)||Physicians Total Care Inc. (repackager)|
|35356-0130||Lake Erie Medical and Surgical Supply (repackager)|
Related images for "4833M 15/850"
More about ActoPlus Met (metformin / pioglitazone)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: antidiabetic combinations
- FDA approval history
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.